Company Solutions

BSP Medical is a ground-breaking biomedical technology company, revolutionizing non-invasive diagnosis, monitoring and management of cardiac diseases, through its proprietary HyperQ technology for High Frequency ECG analysis.

BSP Medical is devoted to promoting HyperQ technology and its clinical implementation, offering superior management and care for cardiac patients.

BSP Medical’s software solutions - HyperQ Analyzer Stress and HyperQ Analyzer Rest - are CE marked, FDA cleared, NMPA (Chinese regulation) approved and AMAR (Israel) approved.

We further develop our technology into new areas, including implantable devices and wearable solutions, to provide caregiving organizations, physicians and patients with critical advanced warning for evolving cardiovascular pathologies.

HyperQ technology has been validated in numerous studies and routine clinical use on thousands of patients in Europe, Asia, Israel and the US, demonstrating its crucial value for the detection and monitoring of the #1 global killer - Cardiac Diseases.

Looking For

Investments and collaborations:
We are developing exciting new life-savings applications for high-risk patients with implanted pacemakers or defibrillators, for providing early notice of severe cardiac events. For that we will welcome capital investments as well as cooperation with implantable device manufacturers.

Distributors:
Our existing HyperQ Stress and Rest products are CE marked, FDA cleared and AMAR approved. We are looking for distributors that can develop new markets for stand-alone products.

Manufacturers:
We welcome manufacturers of high-frequency enabled ECG devices to integrate our application and provide your customers with the power of high-frequency QRS analysis and its proven value for accurate detection and monitoring of cardiac diseases.